Home › NDC Lookup › RxCUI directory › RxCUI 540411

Eszopiclone 3 MG Oral Tablet [Lunesta] — RxCUI 540411

RxNorm drug concept · Semantic branded drug
RxCUI 540411 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI540411
Official nameEszopiclone 3 MG Oral Tablet [Lunesta]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLunesta 3 MG Oral Tablet
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Eszopiclone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats insomnia. In studies it helped people fall asleep faster and stay asleep. It is meant to be taken right at bedtime.
  • Take it by mouth right before bed, when you can get a full 7 to 8 hours of sleep. Avoid taking it with or right after a heavy, high-fat meal, since that can slow it down. Follow yo...
  • The most common are an unpleasant taste in your mouth, headache, sleepiness, dizziness, and dry mouth. Some people feel drowsy the next day, so be careful driving until you know ho...
  • If you sleep-walk, sleep-drive, or do things like eat or make calls while not fully awake, stop it and call your doctor. Also get help right away for swelling of the tongue or thro...
📖 Read our full Eszopiclone guide →

🕸️ Concept Web — How Eszopiclone 3 MG Oral Tablet [Lunesta] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Eszopiclone 3 MG Oral Tablet [Lunesta] RxCUI 540411

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Eszopiclone 461016
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lunesta 540404
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Eszopiclone Oral Tablet 485439
    • Eszopiclone Oral Product 1156807
    • Eszopiclone Pill 1156808
    • Eszopiclone Oral Tablet [Lunesta] 540406
    • Lunesta Oral Product 1181484
    • Lunesta Pill 1181485
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Eszopiclone 3 MG Oral Tablet SCD · 485465
  • Eszopiclone 3 MG SCDC · 485464
  • Eszopiclone Oral Tablet SCDF · 485439
  • Eszopiclone Oral Product SCDG · 1156807
  • Eszopiclone Pill SCDG · 1156808

Brand-Name Concepts

  • Eszopiclone 3 MG [Lunesta] SBDC · 540410
  • Eszopiclone Oral Tablet [Lunesta] SBDF · 540406
  • Lunesta Oral Product SBDG · 1181484
  • Lunesta Pill SBDG · 1181485
  • Lunesta BN · 540404

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 540411 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80725-0010-30 30 TABLET, COATED in 1 BOTTLE (80725-010-30) Lunesta Waylis Therapeutics LLC 2023-08-15
80725-0011-30 30 TABLET, COATED in 1 BOTTLE (80725-011-30) Lunesta Waylis Therapeutics LLC 2023-08-15
80725-0012-30 30 TABLET, COATED in 1 BOTTLE (80725-012-30) Lunesta Waylis Therapeutics LLC 2023-08-15
Observed labelers: Waylis Therapeutics LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.